WY-5

N/A

Report date: 2022/01/10 10:59:56
NME

Base Information

Drug NameWY-5
Drug Alias NameWY-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Liangjiang New Area People's HospitalChongqing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Medical UniversityChongqing Liangjiang New Area People's Hospital
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A